Celecoxib and melatonin in prevention of female rat mammary carcinogenesis

Neoplasma

Volumn 56, Issue 3, 2009, Pages 252-258

  Orendas, P ^a   Kassayova, M ^a   Kajo, K ^b   Ahlers, I ^a   Kubatka, P ^b   Bojkova, B ^a   Pec, M ^b   Ahlersova, E ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b University Teaching Hospital in Martin   (Slovakia)

Author keywords

Celecoxib; Female rats; Mammary carcinogenesis; Melatonin

Indexed keywords

CELECOXIB; DRINKING WATER; MELATONIN; METHYLNITROSOUREA; ANTINEOPLASTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CARCINOGENESIS; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG EFFECT; EATING; EXPERIMENTAL NEOPLASM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; DRUG THERAPY, COMBINATION; EATING; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MELATONIN; METHYLNITROSOUREA; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 67650284155     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_03_252     Document Type: Article

References (31)

1. Mazhar D, Ang R, Waxman J et al. Cox inhibitors and breast cancer. Brit J Cancer 2006; 94: 346-350. doi:10.1038/ sj.bjc.6602942
2. Mandami M, Rochon PA, Juurlink DN et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs Brit Med J 2002; 325: 624-630. doi:10.1136/bmj.325.7365.624
3. Thun MJ, Namboodiri MM, Heath CWJ. Aspirin use and reduced risk of fatal colon cancer, N Engl J Med 1991; 325: 1593-1596.
4. Harris RE, Kasbari S, Farrar WB. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol rep 1999; 6: 71-73.
5. Nelson JE, Harris RE. Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study. Oncol Rep 2000; 7: 169-170.
6. Harris RE, Berne-Donk J, Schuller HM. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol Rep 2002; 9: 693-695.
7. Harris RE, Alshafie GA, Abou-Issa H et al. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res 2000; 60: 2101-2103. (Pubitemid 30225166)
8. Nakatsugi S, Ohta T, Kawamori T et al. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PHIP)- induced mammary gland carcinogenesis in rats. Jpn J Cancer Res 2000; 91: 886-892.
9. môciková-Kalická K, Bojková B, Adámeková E et al. Preventive effect of indomethacin and melatonin on 7,12-dimethylbenz( a)anthracene-induced mammary carcinogenesis in female Sprague-Dawley rats. A preliminary report, Folia Biol (Prague) 2001; 47: 75-79.
10. Orendáš P, Kassayová M, Ahlers I et al. The chemopreventive effect of diclofenac in mammary carcinogenesis in female Sprague-Dawley rats. Proceedings of 7th Slovak Seminar In Animal Physiology, Nitra 2007, pp 243-250 /in Slovak/.
11. Kubatka P, Kalická K, Chamilová M et al. Nimesulide and melatonin in mammary carcinogenesis prevention in female sprague-dawley rats. Neoplasma 2002; 49: 255-259. (Pubitemid 35051909)
12. Kubatka P, Ahlers I, Ahlersová E et al. Chemoprevention of mammary carcinogenesis in female rats by rofecoxib. Cancer Lett 2003; 202: 131-136. doi:10.1016/j.canlet.2003.08.006 (Pubitemid 37485885)
13. Orendáš P, Ahlers I, Kubatka P et al. Etoricoxib in the prevention of rat mammary carcinogenesis. Acta Vet (brno) 2007; 76: 613-618. doi:10.2754/avb200776040613 (Pubitemid 351569943)
14. Howard PA, Delafontaine P. Nonsteroidal anti-inflammatory drugs and cardiovascular risk, J Am Coll Cardiol 2004; 43: 519-525. doi:10.1016/j.jacc. 2003.09.043 (Pubitemid 38229519)
15. Kearney PM, Baigent C, Godwin J et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. Brit Med J 2006; 332: 1302-1308. doi:10.1136/bmj.332.7553.1302 (Pubitemid 44365384)
16. Mitchell JA, Warner TD. Cox isoforms in the cardiovascular system: understanding the activities of non-steroidal antiinflammatory drugs. Nat Rev Drug Discov 2006; 5: 75-86. doi:10.1038/nrd1929
17. Sánchez-Barceló EJ, Cos S, Mediavilla MD. Influence of pineal gland function on the initiation and growth of hormone- dependent breast tumors. Possible mechanisms. In: Gupta D, Attanasio A, Reiter RJ, editors. The pineal gland and Cancer: Brain Research Promotion. London-Tubingen, 1988: 221-232.
18. Blask DE, Pelletier DB, Hill SM. Pineal melatonin inhibition of tumor promotion in the N-nitroso N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J. Cancer Res. 1991; 117: 526-532. doi:10.1007/bf01613283
19. Blask DE, Hill SM. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J Neural Transm (suppl) 1986; 21: 433-449.
20. Pandi-Perumal SR, Srinivasan V, Maestroni GJM et al. Melatonin: Nature's most versatile biological signal? FEBS J 2006; 273 (13), 2813-2838. doi:10.1111/j.1742-4658.2006.05322.x
21. Steinbach G, Lynch PM, Phillips RK et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 1946-1952 doi:10.1056/ NEJM200006293422603 (Pubitemid 30419089)
22. Harris RE, Beebe-Donk J, Doss H et al. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade. Oncol Rep 2005; 13: 559-583.
23. Harris RE , Beebe-Donk J, Alshafie G. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 2006; 6: 27. doi:10.1186/1471-2407-6-27 (Pubitemid 43264309)
24. Mc Cormick DL, Madigan MJ, Moon RC. Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res 1985; 45: 1803-1808. (Pubitemid 15079141)
25. Abou-Issa HM, Alshafie GA, Seibert K et al. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Anticancer Res 2001; 21: 3425-3432. (Pubitemid 34224247)
26. Ahlersováe, Ahlers I, Kubatka P et al. Melatonin and retinyl acetate as chemopreventives in DMBA-induced mammary carcinogenesis in female Sprague-Dawley rats. Folia Biol (Prague) 2000; 46: 69-72. (Pubitemid 30235017)
27. Bojková B, Kubatka P, Môciková K et al. Effects of retinyl acetate and melatonin on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. A Preliminary Report. Folia Biol (Prague) 2000; 46: 73-76.
28. Kubatka P, Bojková B, Kalická K et al. Preventive effects of raloxifene and melatonin in N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats. Neoplasma 2001; 48: 313-319. (Pubitemid 32802445)
29. Blask DE, Hill SM, Orstead KM et al. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethyl-benz(a)anthracene (DMBA)-induced mammary tumorigenesis. J Neural Transm 1986; 67: 125-138. doi:10.1007/BF01243365
30. Kassayová M, Friedmanová L, Orendáš P et al. Effect of prolonged psychoemotional stress and melatonin on experimental mammary carcinogenesis in female rats. Neoplasma 2007; 54 (3): 251-255.
31. Mayo JC, Sainz RM, Tan DX et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005; 165: 139-149. doi:10.1016/j.jneuroim.2005.05.002